Coherus Oncology
CHRS
CHRS
205 hedge funds and large institutions have $1.17B invested in Coherus Oncology in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 77 increasing their positions, 66 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
10.17% less ownership
Funds ownership: 120.54% → 110.37% (-10%)
22% less capital invested
Capital invested by funds: $1.51B → $1.17B (-$335M)
49% less call options, than puts
Call options by funds: $787K | Put options by funds: $1.54M
Holders
205
Holding in Top 10
3
Calls
$787K
Puts
$1.54M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$9.96M | |
| 3 | +$8.05M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$7.52M |
| 5 |
Millennium Management
New York
|
+$5.89M |
Top Sellers
| 1 | -$38.2M | |
| 2 | -$29.8M | |
| 3 | -$28.4M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$20.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$13.7M |